Affordable Access

Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study.

Authors
  • Gosse, P
  • Sheridan, D J
  • Zannad, F
  • Dubourg, O
  • Guéret, P
  • Karpov, Y
  • de Leeuw, P W
  • Palma-Gamiz, J L
  • Pessina, A
  • Motz, W
  • Degaute, J P
  • Chastang, C
Type
Published Article
Journal
Journal of Hypertension
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Oct 01, 2000
Volume
18
Issue
10
Pages
1465–1475
Identifiers
PMID: 11057435
Source
Medline
License
Unknown

Abstract

Indapamide SR 1.5 mg was significantly more effective than enalapril 20 mg at reducing LVMI in hypertensive patients with LVH.

Report this publication

Statistics

Seen <100 times